PRE 14A XBRL

PROXY STATEMENT

Company: ADIAL PHARMACEUTICALS, INC.
Filed: May 23, 2025
Period of Report: May 23, 2025
Accession Number: 0001213900-25-047423

View Document ↗ View on SEC.gov ↗